Progentec Diagnostics
PrivateLast Round
Grant
Apr 9, 2026
Total Funding Raised
$6.48M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Progentec Diagnostics operates in Healthcare & Life Sciences and is based in Oklahoma City, Oklahoma. Its latest recorded funding round was a Grant round in April 2026.
Progentec Diagnostics is a biotechnology company that develops proactive care solutions for systemic lupus erythematosus, multiple sclerosis, and other autoimmune diseases powered by proteomics and digital health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Progentec Diagnostics Comparables
Compare Progentec Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AMPEL BioSolutions | 87% | |
| Exagen Inc. | 80% | |
| GLX Analytix | 76% |
For institutional investors. Book with your work email.
Progentec Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 9, 2026 | ||||
| Series A | Jan 8, 2020 | ||||
| Grant | Jul 25, 2019 | ||||
| Early Funding | Oct 31, 2018 | ||||
| Seed | Nov 27, 2017 |
For institutional investors. Book with your work email.
Progentec Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Seed, Early Funding |
| Plains Ventures | Series A |
| Mayo Clinic Ventures | Seed |
| Oklahoma Center for the Advancement of Science and Technology | Grant |
| OCA Ventures | Seed, Series A, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 59% MoM.
- Jul 25, 2026
Monthly visitors increased 41% MoM, reaching 2K.
For institutional investors. Book with your work email.
Progentec Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Progentec Diagnostics's valuation, stock price, and market status.
Is Progentec Diagnostics a public or private company?
Progentec Diagnostics is a private company.
What is the current stock price of Progentec Diagnostics?
Progentec Diagnostics is a private company, so its shares have no public market price. Caplight tracks Progentec Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Progentec Diagnostics worth (valuation)?
Valuation information for Progentec Diagnostics is not publicly available.
Can I buy Progentec Diagnostics stock?
Progentec Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Progentec Diagnostics's last funding round?
Progentec Diagnostics's most recent funding round was Grant on April 9, 2026.
Who are the main investors in Progentec Diagnostics?
Key investors in Progentec Diagnostics include i2E, Plains Ventures, OCA Ventures.
Will Progentec Diagnostics IPO soon?
No public IPO plans have been announced for Progentec Diagnostics.
How can I track Progentec Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Progentec Diagnostics's shares on secondary markets.